Aim: To investigate the effect of chronic nicotine treatment on vascular function and to identify the underlying mechanisms. Methods: Adult rats were treated with nicotine (3 mg·kg -1 ·d -1
Introduction
Nicotine is a well-known compound with extensive and complex effects on the cardiovascular system [1] . Research on nicotine and nicotinic acetylcholine receptors (nAChRs) has revealed that the chronic effect of nicotine may differ from the acute effect [2] [3] [4] . To fully understand the role of nicotine, it is necessary to investigate its chronic effect. Recently, studies from our group and others on chronic nicotine exposure have reported several novel effects, such as enhancing insulin sensitivity [2, 5] , augmenting insulin-induced mitogenic signaling [6] , and improving cognition [7] . Most studies on the vascular function of nicotine focus on its acute effect [8, 9] , while studies on its chronic effect focused mainly on fetal and neonatal nicotine exposure [10] [11] [12] . One of the latter studies reported that prenatal exposure to nicotine led to an increase in the amount of periaortic adventitial fat in the offspring and impaired the inhibitory effect of adventitial fat on vascular contraction [12] . However, our previous study on nicotine cessation and obesity demonstrated that chronic nicotine exposure in adult rats induces a significant reduction in periaortic adventitial fat after 6 weeks of nicotine treatment [13] . Given that the chronic nicotine effects on vascular function in adults are largely unknown, and the unanswered question of whether the decreased amount of periaortic fat in our chronic nicotine exposure rat model affects vascular function, we designed the present study.
Our results indicate that chronic nicotine exposure does not affect vascular adventitial fat and endothelium function, but specifically enhances vascular smooth muscle relaxation. This chronic nicotine effect on smooth muscle relaxation is mediated through a cGMP-dependent PKG pathway. Our findings reveal a novel effect of nicotine on vascular function and link nicotine to the nitric oxide relaxation pathway, thus contributing to a more comprehensive understanding of nicotine pharmacology.
Animal treatment
To study the effect of nicotine on aortic function, SpragueDawley rats aged 10-11 weeks were divided into two groups. The saline group received a subcutaneous injection of saline, and the nicotine group received a subcutaneous injection of nicotine (3 mg·kg -1 ·d -1 ) [5, 13] . Drug dosage was adjusted once a week according to the body weight. Organ chamber studies were performed and tissue samples were collected for histological sections or molecular biology study after 6 weeks of treatment.
In time course study, Sprague-Dawley rats were treated as above mentioned and were sacrificed at 1 week, 3 weeks and 6 weeks respectively for organ chamber study.
Organ chamber studies Aortic rings were prepared and vascular reactivity was measured using our previous methods [14] [15] [16] . The rats were anesthetized with sodium pentobarbital (60 mg/kg, ip). After opening the thoracic cavity, the descending thoracic aorta was immediately removed and placed in cold Krebs-Henseleit solution of the following composition (mmol/L): NaCl 118.4, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25.0, glucose 11.1 and CaNa 2 -EDTA 0.026, and aerated with 95% O 2 and 5% CO 2 . Rat aorta was cut into 5 mm-wide rings. Four types of rings were prepared in our studies: F+E+: aortic rings with intact adventitial fat and endothelium, F-E+: aortic rings with intact endothelium but adventitial fat removed, F+E-: aortic rings with intact adventitial fat but endothelium removed, F-E-: aortic rings without adventitial fat and endothelium. The aortic rings were suspended in conventional organ baths filled with 20 mL Krebs-Henseleit solution, maintained at 37 °C and continuously aerated with 95% O 2 and 5% CO 2 . Changes in isometric tension were recorded using an IT1-25 transducer and an IOX computerized system (EMKA Technologies, Paris, France). Each aortic ring was allowed to equilibrate for 60 min at a resting tension of 2.0 g.
In experiments designed to examine vascular contractility, aortic rings were exposed to cumulative concentrations of phenylephrine (10 -9 to 10 -4 mol/L). In experiments designed to examine vascular relaxation, aortic rings were precontracted with a single dose of phenylephrine (3×10 -7 mol/L) for 25 min and then exposed to cumulative concentrations of acetylcholine (10 -8 to 3×10 -4 mol/L), sodium nitroprusside (10 -10 to 10 -4 mol/L), or 8-Br-cGMP (10 -6 to 3×10 -4 mol/L). Except in one experiment, aortic rings were precontracted with cumulative concentrations of phenylephrine (10 -9 to 3×10 -5 mol/L), and then exposed to a single dose of ACh (3×10 -6 mol/L) and SNP (10 -4 mol/L) successively. In experiments designed to study the underlying mechanisms, aortic rings were generally preincubated with various blockers for 40 min before exposure to sodium nitroprusside. At the end of each experiment, acetylcholine (3×10 -6 mol/L) was used to verify the completely removal of endothelial cells from aortic rings.
Western blotting analysis cGMP-dependent protein kinase (PKG) protein expression was examined by SDS-PAGE and immunoblotting as described previously [17, 18] . Anti-PKG type I polyclonal antibody was from Stressgen (MI, USA). Goat anti-rabbit IgG:HRP (Stressgen, Ann Arbor, MI, USA) was used as the secondary antibody for PKG detection by enhanced chemiluminescence immunoblot analysis. Each experiment was repeated at least three times.
Measurement of PKG activity
Enzyme activity assay of PKG was performed according to the manufacturer's instructions (Genmed Scientifics Inc, Arlington, MA, Shanghai Branch) by coupling the formation of ADP to the reaction catalyzed by PK and LDH in the presence of phosphoenolpyruvate (PEP) with the oxidation of NADH [19] . Briefly, assays were conducted for 5 min at 30 °C in a reaction mixture of final volume 100 µL containing aortic medial lysate (8 μL), MOPS (pH 7.5), EDTA, cGMP, magnesium acetate, ATP, PEP, NADH, PK, LDH, selective heptapeptide glasstide RKRSRAE and QKRPRRKDTP [20] . The disappearance of NADH was detected by measuring a decrease in extinction at 340 nm (ε=6 220 M -1 ·cm -1 ) spectrophotometrically. PKG enzyme activity was expressed as unit per milligram of protein (unit: μmol NADH min -1 ).
Morphological examination
Animals were weighed and sacrificed under anesthesia with pentobarbital sodium (60 mg/kg, ip). The thoracic cavity was opened immediately. The aorta was excised and rinsed in cold physiological saline. Just below the branch of the left subclavicular artery, a 20-mm-long segment of thoracic aorta and periaortic fat was harvested, blotted and weighed. Vascular morphometry was performed in a blind fashion using coded slides of 4-mm-thick histological sections stained with hematoxylin and eosin. Vascular morphometry was performed using computer-assisted image analysis, as previously described [21] . In each rat, four cross-sections of thoracic aorta were measured to calculate the mean values.
Reagents
The following drugs were used in this study (unless otherwise specified, all were obtained from Sigma-Aldrich): phenyleph- Drugs were dissolved initially in distilled deionized water (except for ODQ which was dissolved in dimethyl sulphoxide) 
Statistical analysis
All data are reported as mean±SEM. Statistical analysis was performed with a two-tailed Student's unpaired t test, except for the vascular reactivity study, for which two-way ANOVA for repeated measures was used to compare two curves. The threshold for statistical significance was P<0.05.
Results
Regulation of adventitial fat on vascular contraction and relaxation in rat aortas Periaortic adventitial fat can inhibit vascular contraction, and this anticontractile effect is thought to be associated with adventitial fat-derived relaxing factor(s), called ADRF [22] . We compared phenylephrine-induced contractions in four types of rat descending thoracic aortic preparations, F+E+ (both fat and endothelium intact), F-E+ (fat removed and endothelium intact), F+E-(fat intact and endothelium removed), and F-E-(both fat and endothelium removed). Periaortic fat demonstrated a significant anticontractile effect in preparations with endothelium (F+E+ vs F-E+, Figure 1A , Table 1 ), but this was markedly reduced in preparations without endothelium (F+E-vs F-E-, Figure 1B , Table 1 ). The anticontractile effects of the fat appeared weaker than those of the endothelium ( Figure  1C , F+E+ vs F+E-, or F-E+ vs F-E-, Table 1 ). The endothelial anticontractile effect was also reduced after removal of the fat ( Figure 1C ), indicating the existence of crosstalk between adventitial fat and endothelium leading to the inhibition on vascular contraction. We also investigated contractions induced by 5-hydroxytryptamine. Similarly, the contractions significantly increased after removal of the fat in preparations with endothelium (F+E+ vs F-E+, Figure 1D , Table 1 ). This anticontractile effect of fat became small in preparations without endothelium (F+E-vs F-E-, Figure 1E , Table 1 ). The anticontractile effect of the endothelium also decreased approximately 50% after removal of the fat, but was still stronger than the anticontractile effect of the fat ( Figure 1F , F+E+ vs F+E-, or F-E+ vs F-E-, Table 1 ). In addition, acetylcholine induced endothelium-dependent relaxation and sodium nitroprusside induced endothelium-independent relaxation were not affected by periaortic fat ( Figure 1G and 1H, Table 1 ).
Chronic nicotine treatment does not alter adventitial fat and endothelial function or smooth muscle contraction, but specifically enhances smooth muscle relaxation in rat aortas After 6 weeks of nicotine treatment, both periaortic fat weight and the area of the thoracic aortas were significantly reduced, while aortic weight and wall area remained unchanged (Figure 2A-2D ). Phenylephrine induced contractions were measured in F+E+ and F-E+ aortic preparations, and there were no significant differences between the saline and nicotine groups. The anticontractile effects of the adventitial fat (F+E+ vs F-E+) were also similar in the saline and nicotine groups ( Figure 2E ), indicating that periaortic fat reduction by nicotine does not affect the adventitial fat function.
Acetylcholine induced relaxation was further determined in F-E+ aortic preparations, and a significant increase was observed in the nicotine compared with the saline group ( Figure 2F ). Because the endothelium-dependent relaxation by acetylcholine is due to nitric oxide (NO) release from the endothelial cells and subsequently NO action on the underlying smooth muscle cells, additional experiments were performed to identify whether the effects could be localized to the endothelium or smooth muscle ( Figure 2G ). Phenylephrine induced contractions were not different in either F-E+ or F-Eaortic preparations between the saline and nicotine groups, and the anticontractile effects of the endothelium (F-E+ vs F-E-) were also similar in both groups ( Figure 2G and 2H, Table 2 ). In addition to an increase in endothelium-dependent relaxation by acetylcholine, endothelium-independent relaxation by NO donor, sodium nitroprusside, were increased in the nicotine compared with the saline group ( Figure 2G , 2I, and 2J), indicating that chronic nicotine treatment improves smooth muscle responses to NO. The above data ( Figure  2F -2J) also suggest that nicotine does not alter endothelial function.
We further determined smooth muscle contraction and relaxation in F-E-aortic preparations from saline and nicotine-treated rats. Similar to the above data ( Figure 2H ), phenylephrine induced smooth muscle contractions were not dif- Figure 3A and 3B). As expected, the dose-response curve for sodium nitroprusside induced aortic relaxation shifted to the left, further supporting that smooth muscle responses to NO are enhanced after chronic administration of nicotine in rats ( Figure 3C , Table 2 ).
Chronic nicotine treatment enhances aortic smooth muscle relaxation in rats in a time-dependent manner We next investigated the time course of chronic nicotine effects on smooth muscle relaxation. F-E-aortic preparations were evaluated. One week of nicotine treatment did not affect the dose-response curve of nitroprusside induced aortic relaxation, whereas nicotine treatment for 3 or 6 weeks significantly shifted nitroprusside dose-response curves to the left ( Figure  4 , Table 3 ). It appeared that the differences in smooth muscle relaxation between the saline and nicotine groups became more significant and stable after 6-weeks of treatment ( Figure  4) . Chronic nicotine treatment enhances aortic smooth muscle relaxation induced by sodium nitroprusside through a cGMPdependent PKG pathway We further investigated the underlying mechanism in F-Eaortic preparations from saline and nicotine-treated rats. Endothelium independent relaxation induced by sodium nitroprusside is mediated via NO, an intracellular byproduct of sodium nitroprusside. NO can in turn induce smooth muscle relaxation through a cGMP-dependent or independent pathway [23] . We explored whether the differential relaxation between the saline and nicotine group was due to alterations in the cGMP-dependent pathway. NO increases the concentration of cGMP by activation of the soluble guanylyl cyclase (sGC). Pretreatment with the sGC inhibitor, ODQ [24] , markedly reduced sodium nitroprusside induced relaxation in both saline and nicotine groups and abolished the significant difference in relaxation between the two groups ( Figure  5A , Table 4 ). When we used a cGMP analog, 8-Br-cGMP [25] instead of sodium nitroprusside to induce relaxation, the dose-response curve for 8-Br-cGMP induced aortic relaxations significantly shifted to the left similar to sodium nitroprusside in the nicotine treated group ( Figure 5B ). The EC 50 values of 8-Br-cGMP for aortic relaxation were 5×10 -5 mol/L for the saline group and 3×10 -5 mol/L for the nicotine group (P<0.05 between two groups). The maximal relaxation values attained with 8-Br-cGMP were also increased by 13% in the nicotine group (P<0.01 between two groups). Moreover, pretreatment with the cGMP dependent protein kinase (PKG) inhibitor Rp- 
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Acta Pharmacologica Sinica npg 8-Br-PET-cGMP [26] not only shifted the sodium nitroprussideinduced relaxation to the right in both groups, but also abolished the relaxation difference between two groups ( Figure  5C , Table 4 ). Thus, nitroprusside-induced relaxation enhancement by chronic nicotine treatment occurs in a cGMP dependent PKG pathway and the affected targets are not upstream of PKG. We then examined PKG protein expression and activity ( Figure 5D and 5E). No significant differences were found between saline and nicotine treated groups. These results indicate that the related targets affected by chronic nicotine treatment are located in the PKG downstream pathway.
Discussion
In the present study, we studied the effect of chronic nicotine exposure on vascular function and sought to identify the mechanisms underlying this effect. We found that chronic nicotine treatment in adult animals enhances aortic smooth muscle relaxation, without alterations in adventitial fat and endothelium function or smooth muscle contraction. Detailed exploration of the cGMP-dependent PKG relaxation pathway revealed that PKG downstream targets are responsible for the nicotine-induced enhancement of vascular relaxation.
In our study, chronic nicotine treatment did not affect endothelium dependent relaxation and anticontractile function in the rat aorta. Consistent with our results, Zhang et al noted that nicotine did not damage endothelial cells and did not reduce endothelium-dependent dilatation in rat and man [27] . Some previous reports correlated nicotine with impaired endothelium dependent relaxation, mainly due to free radical production [1] . However, these studies mainly focused on resistance and small arteries. Some of them observed the effect of cigarette extractions rather than that of nicotine. Furthermore, in most previous reports, the duration of nicotine treatment was relatively short or acute. Studies have revealed that the effects of chronic nicotine exposure differ from those of acute exposure due to the complex characteristics of nAChRs [3, 4] . The duration of nicotine treatment in our experiment was six weeks and more accurately reflected the long-term effect of nicotine on vascular function.
However, based on the present results, there is the possibility that basal NO release from endothelium rather than acetylcholine induced NO release might be reduced in the nicotine group. Similar degrees of relaxation enhancement induced by either acetylcholine or sodium nitroprusside were observed in the nicotine group ( Figure 2I and 2J) , suggesting an equal amount of NO release induced by acetylcholine stimulation in the saline and nicotine groups. However, phenylephrine induced contractions in aortas with and without endothelium reflect basal NO release ( Figure 2H ). If basal NO release was the same between the nicotine and saline groups, the anticontractile effect in the nicotine group should have been stronger. In fact, there was a trend towards enhanced anticontractile effect in the nicotine group, but it was not statistically significant. Thus, chronic nicotine treatment may reduce basal NO production.
Regarding nicotine effect on adventitial fat, only one previous study observed an effect of prenatal nicotine exposure on the amount and function of postnatal periaortic fat [12] . The study demonstrated that prenatal nicotine exposure increased the amount of periaortic fat and impaired the anti-contractile function of periaortic fat in the offspring. However, results from our study in adult rats indicated that chronic nicotine treatment did not alter the anti-contractile function of adventitial fat, in spite of the decreased amount of the fat. Two main factors probably contribute to this discrepancy. First, the remaining adventitial fat still possessed anticontractile function [28] . Second, the function of adventitial fat probably changed and may involve some mechanism of compensation to supplement the loss due to reduced adventitial fat. It is very likely that fat may be more effective after nicotine treatment. Nicotine has a direct effect on the function of adipocytes. Many types of nicotinic acetylcholine receptors have been reported to be expressed in rat adipocytes [3] . In fact, it has been reported that chronic nicotine treatment improves fat insulin sensitivity [29] , suggesting a more effective function of fat after nicotine treatment.
The most important finding of our study is that chronic nicotine treatment enhances endothelium independent smooth muscle relaxation, without altering smooth muscle contraction. This effect has been demonstrated in several of our experiments. We also found that the smooth muscle relaxation enhancing effect of nicotine was time dependent. The extent of relaxation gradually increased over the 6-week duration of nicotine treatment in Sprague-Dawley rats. The time point of six weeks after treatment was suitable for further mechanistic studies, because at this time the relaxation difference [8] . However, quite different from our findings, they only observed the direct and acute effect of nicotine in isolated aortas. While in our model, nicotine did not enhance relaxation of the aorta after a 1 week treatment. Moreover, while they found that α7-nAChR mediated vasorelaxation was endothelium dependent, in our model, the relaxation enhancing effect of nicotine was endothelium independent.
In agreement with our results, the basal blood pressure is usually slightly lower in smokers [30, 31] . One study also evaluated forearm blood flow in healthy smokers and non-smokers and found that smokers were more sensitive to endothelium independent relaxation stimulus than non-smokers, though the mechanism was unclear [31] . Contrary to our results, another study in cerebral arterioles found that nicotine impaired NO-induced endothelium independent relaxation [32] . Their experiments differed in that they used a relatively higher nicotine dose (4.5 mg·kg -1 ·d -1 ), a shorter treatment duration (2-3 weeks) and female rats. In addition, Wang et al reported that chronic nicotine exposure increased canonical transient receptor potential (TRPC) expression in pulmonary arterial smooth muscle [33] , which contributed to the increases in basal intracellular concentration of Ca 2+ , constriction and remodeling of pulmonary arterial smooth muscle. In addition to the difference in administration, the nicotine dose and treatment duration, different features of various vascular beds probably account for the disparity. TRPC4 and TRPC6 have been shown to be expressed predominantly in rat pulmonary artery smooth muscle. However, we previously noted that mRNA expression of TRPC4 and TRPC6 were not at detectable levels in rat aortic smooth muscle of rat either in the control or nicotine treated group (data not shown).
Current results suggest that a PKG downstream target is responsible for the nicotine-induced enhancement of vascular relaxation. Two main mechanisms involved in PKG-mediated smooth muscle relaxation are cytosolic Ca 2+ concentration reduction and Ca 2+ desensitization [34] . In addition, PKG can also mediate vascular relaxation through thin filament regulation [35, 36] . It is not likely that nicotine augments relaxation through Ca 2+ desensitization, because Ca 2+ dependent contractions induced by phenylephrine or 5-hydroxytryptamine are not altered. Nicotine has been reported to regulate PKG downstream target BK Ca in cerebral arterioles [32] . However, further organ bath studies eliminated the involvement of most potassium channels expressed in vascular smooth muscle cells, including BK Ca (data not shown). Another important Ca 2+ dependent target sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase (SERCA) was also eliminated. Future studies are needed to explore other Ca 2+ dependent targets such as the regulator of G protein signaling (RGS) proteins and inositol 1,4,5-trisphosphate receptor (IP 3 R)-associated cGMP kinase substrate (IRAG) [34] . Meanwhile, heat shock protein 20 (HSP20), an important protein affecting thin filament regulation [37, 38] , should also be considered. HSP20 is constitutively expressed in vascular smooth muscle and can be phosphorylated by cyclic nucleotide-dependent protein kinases [36, 39, 40] . Phosphorylation of HSP20 is very effective for smooth muscle relaxation. Increases in the expression or phosphorylation of HSP20 under different physiological and pathophysiological conditions correlate with enhanced smooth muscle relaxation [35] . We report for the first time that nicotine enhances the sensitivity of the NO relaxation pathway in vascular smooth muscle. This effect of nicotine may be mediated through a known or unknown PKG downstream pathway. These findings contribute to a deeper understanding of nicotine pharmacology and its involvement in the vascular relaxation pathways. Considering that enhanced vascular relaxation or sensitivity of the NO/cGMP/PKG pathway benefits many clinical diseases, our study presents valuable information that could be applied to the development of new clinical therapeutic approaches to these diseases.
